These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 6861617
1. Serum folic acid levels and antipyrine clearance rates in smokers and non-smokers. Nakazawa Y, Chiba K, Imatoh N, Kotorii T, Sakamoto T, Ishizaki T. Drug Alcohol Depend; 1983 Apr; 11(2):201-7. PubMed ID: 6861617 [Abstract] [Full Text] [Related]
2. The use of single sample clearance estimates to probe hepatic drug metabolism: handprinting the influence of cigarette smoking on human hepatic drug metabolism. Bachmann KA, Nunlee M, Martin M, Schwartz J, Jauregui L, Forney RB. Xenobiotica; 1990 May; 20(5):537-47. PubMed ID: 2112290 [Abstract] [Full Text] [Related]
3. Enhanced antipyrine metabolism in cigarette smokers in Indian population. Uppal R, Garg SK, Sharma PR, Nair CR, Chaudhury RR. Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):269-71. PubMed ID: 7450928 [Abstract] [Full Text] [Related]
4. Saliva and plasma clearance of antipyrine as reflectors of liver function. Luoma PV, Sotaniemi EA. Eur J Drug Metab Pharmacokinet; 1981 Jun; 6(4):261-4. PubMed ID: 7333326 [Abstract] [Full Text] [Related]
5. Enhanced drug metabolism in cigarette smokers. Hart P, Farrell GC, Cooksley WG, Powell LW. Br Med J; 1976 Jul 17; 2(6028):147-9. PubMed ID: 1276835 [Abstract] [Full Text] [Related]
6. Microsomal enzymes in patients with gastric carcinoma as determined by plasma half-life of antipyrine. Higuchi T, Nakamura T, Uchino H. Gan; 1978 Dec 17; 69(6):753-6. PubMed ID: 750270 [Abstract] [Full Text] [Related]
7. Antipyrine clearance and metabolite formation: the influence of liver volume and smoking. Spoelstra P, Teunissen MW, Janssens AR, Weeda B, van Duijn W, Koch CW, Breimer DD. Eur J Clin Invest; 1986 Aug 17; 16(4):321-7. PubMed ID: 3093244 [Abstract] [Full Text] [Related]
10. Multiple dose pharmacokinetics of ketoconazole and their effects on antipyrine kinetics in man. Daneshmend TK, Warnock DW, Ene MD, Johnson EM, Parker G, Richardson MD, Roberts CJ. J Antimicrob Chemother; 1983 Aug 17; 12(2):185-8. PubMed ID: 6311786 [Abstract] [Full Text] [Related]
11. [Evaluation of the functional status of hepatic microsomal enzymes in workers exposed to carbon dioxide and vinyl chloride by using the antipyrine test]. Lutz W, Stankiewicz A, Krajewska B. Med Pr; 1987 Aug 17; 38(3):157-66. PubMed ID: 3118136 [Abstract] [Full Text] [Related]
12. Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination. Wood AJ, Vestal RE, Wilkinson GR, Branch RA, Shand DG. Clin Pharmacol Ther; 1979 Jul 17; 26(1):16-20. PubMed ID: 445957 [Abstract] [Full Text] [Related]
13. Antipyrine clearance in patients with Gilbert's syndrome. Ishizaki T, Chiba K, Sasaki T. Eur J Clin Pharmacol; 1984 Jul 17; 27(3):297-302. PubMed ID: 6510457 [Abstract] [Full Text] [Related]
14. A comparative study of antipyrine pharmacokinetics in saliva and plasma using a colourimetric method of antipyrine analysis. Harman AE, Priestly BG, Frewin DB. Clin Exp Pharmacol Physiol; 1977 Jul 17; 4(6):593-6. PubMed ID: 589875 [Abstract] [Full Text] [Related]
15. Pulmonary disease and antipyrine clearance. Laybourn C, Tønnesen P, Loft S, Sonne J, Døssing M. Clin Pharmacol Ther; 1986 Oct 17; 40(4):415-9. PubMed ID: 3489577 [Abstract] [Full Text] [Related]
16. Influence of oral contraceptive use and cigarette smoking, alone and together, on antipyrine pharmacokinetics. Scavone JM, Greenblatt DJ, Abernethy DR, Luna BG, Harmatz JS, Shader RI. J Clin Pharmacol; 1997 May 17; 37(5):437-41. PubMed ID: 9156376 [Abstract] [Full Text] [Related]
18. Simplified determination of antipyrine clearance by liquid chromatography of a microsample of saliva or plasma. el-Yazigi A, Raines DA, Ali H, Sieck J, Ernst P, Dossing M. Pharm Res; 1991 Feb 17; 8(2):269-72. PubMed ID: 2023880 [Abstract] [Full Text] [Related]
19. Antipyrine clearance and metabolism in patients with psoriasis. Kubota K, Ishizaki T, Chiba K, Takagi A, Nakagawa A, Nakamura K. Br J Clin Pharmacol; 1986 Oct 17; 22(4):455-62. PubMed ID: 3768257 [Abstract] [Full Text] [Related]
20. Intravenous epoprostenol sodium does not increase hepatic microsomal enzyme activity in rats. Carlton LD, Schmith VD, Brouwer KL. Prostaglandins; 1995 Oct 17; 50(5-6):341-7. PubMed ID: 8838243 [Abstract] [Full Text] [Related] Page: [Next] [New Search]